SAN FRANCISCO--(BUSINESS WIRE)--Amplitude, Inc. (Nasdaq: AMPL), a leading digital analytics platform, today announced the results of the Total Economic Impact™ of Amplitude study conducted by ...
Amplitude released findings from a study of retention data collected from its popular analytics platform and found that the most commonly used retention metric, known as ‘N Day,’ underestimates the ...
(RTTNews) - Johnson & Johnson (JNJ) Tuesday reported encouraging results from the Phase 3 AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate (Akeega) plus prednisone in ...
Learn more New research suggests senior leaders’ distrust of AI is driving inefficient implementation and widening ...